statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.306
SG - Singapore	204
IT - Italia	193
DE - Germania	153
CN - Cina	143
PL - Polonia	101
SE - Svezia	81
FI - Finlandia	75
VN - Vietnam	65
BR - Brasile	57
HK - Hong Kong	51
GB - Regno Unito	45
FR - Francia	36
BD - Bangladesh	32
NL - Olanda	28
RU - Federazione Russa	24
BE - Belgio	21
IN - India	17
KR - Corea	16
MX - Messico	16
JP - Giappone	15
UA - Ucraina	15
TR - Turchia	14
IE - Irlanda	12
BG - Bulgaria	11
AR - Argentina	9
CA - Canada	9
ES - Italia	9
SA - Arabia Saudita	9
TN - Tunisia	8
MA - Marocco	7
CL - Cile	5
CO - Colombia	5
EG - Egitto	5
PH - Filippine	5
SN - Senegal	5
AT - Austria	4
DZ - Algeria	4
IQ - Iraq	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AU - Australia	3
AZ - Azerbaigian	3
ID - Indonesia	3
IL - Israele	3
TW - Taiwan	3
AE - Emirati Arabi Uniti	2
CI - Costa d'Avorio	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
GR - Grecia	2
JM - Giamaica	2
JO - Giordania	2
KG - Kirghizistan	2
PY - Paraguay	2
SK - Slovacchia (Repubblica Slovacca)	2
TH - Thailandia	2
VE - Venezuela	2
AO - Angola	1
BB - Barbados	1
BH - Bahrain	1
BO - Bolivia	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GH - Ghana	1
HN - Honduras	1
IR - Iran	1
IS - Islanda	1
KE - Kenya	1
KZ - Kazakistan	1
LT - Lituania	1
LU - Lussemburgo	1
LV - Lettonia	1
MD - Moldavia	1
MK - Macedonia	1
MM - Myanmar	1
MQ - Martinica	1
MY - Malesia	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PK - Pakistan	1
PT - Portogallo	1
RO - Romania	1
RS - Serbia	1
RW - Ruanda	1
UY - Uruguay	1
Totale	2.896

Nome	#
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants	512
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study	286
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives	267
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients	266
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease	262
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease.	260
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient	253
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay	251
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease	251
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease	236
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome	156
Totale	3.000

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	186	11	12	4	13	10	15	7	6	16	18	21	53
2022/2023	255	23	48	14	41	32	38	1	25	19	4	10	0
2023/2024	156	4	7	8	9	18	18	26	26	4	5	20	11
2024/2025	577	13	23	30	38	43	71	63	62	91	64	43	36
2025/2026	858	103	14	43	63	69	73	105	32	120	129	73	34
2026/2027	1	1	0	0	0	0	0	0	0	0	0	0	0
Totale													3.000

ArTS Archivio della ricerca di Trieste